- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06230731
Oxygenation in Vascular Lesions of the Colon
June 5, 2025 updated by: University of Chicago
The goal of this clinical trial is to evaluate oxygenation in the colon in people with acquired vascular abnormalities in the proximal colon.
Study Overview
Detailed Description
The etiology of acquired vascular abnormalities of the large bowel (i.e.
angiodysplasia, AVM, hemangiomas of the cecum.
etc.) are unknown.
These lesions typical appear as ectatic, dilated, and tortuous blood vessels within the submucosa and mucosa of the GI tract.
In some patients they are the cause of acute large volume bleeding or a slower chronic bleed that manifests as chronic iron deficiency anemia.
These lesions are more common in older individuals and those with underlying cardiac, pulmonary, and renal disease.
As such, it is hypothesized that these lesions may result from chronic hypoxia.
This study aims to evaluate oxygenation of the colon in people with acquired vascular abnormalities in the proximal colon compared to healthy controls.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kristi Kearney, RN
- Phone Number: 773-834-7414
- Email: kkearney@bsd.uchicago.edu
Study Contact Backup
- Name: Joel Pekow, MD
- Phone Number: (773) 834-8632
- Email: jpekow@bsd.uchicago.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- Recruiting
- University of Chicago
-
Contact:
- Kristi Kearney, RN
- Phone Number: 773-834-7414
- Email: kkearney@bsd.uchicago.edu
-
Contact:
- Joel Pekow, MD
- Phone Number: 773-834-8632
- Email: jpekow@bsd.uchicago.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Undergo standard of care colonoscopy
- People with a history of vascular lesions of the colon
- People with healthy colon
- 18 - 89 years of age
Exclusion Criteria:
- Age < 18 years
- Age > 90 years
- People with ulcerations in at ascending colon opposite the ileocecal valve
- Previous colon surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Vascular abnormality group
People with acquired vascular abnormalities in the proximal colon
|
Measure oxygen levels in 5 proximal colon mucosa locations.
|
|
Active Comparator: Control group
People with healthy colon
|
Measure oxygen levels in 5 proximal colon mucosa locations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative analysis of colonic oxygen saturation levels
Time Frame: baseline-12 months
|
Colonic oxygen saturation levels will be compared between patients with vascular lesions of the colon and healthy controls.
|
baseline-12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joel Pekow, MD, University of Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2024
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2029
Study Registration Dates
First Submitted
January 19, 2024
First Submitted That Met QC Criteria
January 19, 2024
First Posted (Actual)
January 30, 2024
Study Record Updates
Last Update Posted (Actual)
June 10, 2025
Last Update Submitted That Met QC Criteria
June 5, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- IRB23-1273
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Lesion
-
Lumenis Be Ltd.Not yet recruitingPigment; Lesion | Lesion; Vascular
-
Lumenis Be Ltd.Emek Medical CenterRecruitingPigmented Lesions | Vascular LesionIsrael
-
Lumenis Be Ltd.CompletedPigmented Lesions | Vascular LesionUnited States
-
Lumenis Be Ltd.Emek Medical CenterRecruitingPigmented Lesions | Vascular LesionIsrael
-
Memorial Sloan Kettering Cancer CenterRecruitingSkin Lesion | Mucosal LesionUnited States
-
Fahad AlKherayfOttawa Hospital Research InstituteUnknownChiasmal; Lesion | Prechiasmal; LesionCanada
-
GuerbetBracco Imaging S.p.A.CompletedCNS Lesion | Lesion in Body RegionJapan
-
Fin-Ceramica Faenza SpaCompletedKnee Chondral Lesion | Knee Osteochondral LesionSwitzerland, Italy, Austria, Belgium, Germany, Norway, Poland, South Africa, Sweden
-
Assistance Publique - Hôpitaux de ParisCompletedCartilage Lesion | Osteochondral LesionFrance
-
Barmherzige Brüder EisenstadtUnknownDegenerative Lesion of Articular Cartilage of Knee | Osteochondral Lesion of Talus
Clinical Trials on Oxygen saturation
-
University of SydneyUniversity of Pennsylvania; University of California, San Diego; University of... and other collaboratorsCompletedInfant, Newborn, Diseases | Infant, Premature, Diseases | Retinopathy of Prematurity | Bronchopulmonary Dysplasia | Infant, Very Low Birth WeightAustralia
-
Spaarne GasthuisRecruitingBronchiolitis | Lower Respiratory Tract Infection | Bronchial HyperreactivityNetherlands
-
Tepecik Training and Research HospitalCompletedComplication | HyperoxiaTurkey
-
Beijing Tiantan HospitalRecruitingPostoperative Delirium | Carotid Endarterectomy | Cerebral Oxygen SaturationChina
-
University of ManitobaUnknownDelirium | Thoracic SurgeryCanada
-
University Hospital, CaenUnknown
-
Children's Hospital Medical Center, CincinnatiWithdrawnInfant, Premature, Diseases | BronchiolitisUnited States
-
Prince Sultan Military Medical CityEnrolling by invitationAirway Reactivity | Hemodynamic Stability During AnesthesiaSaudi Arabia
-
Seoul National University HospitalCompletedKidney Injury, Acute | Transcatheter Aortic Valve ImplantationKorea, Republic of
-
Centre Hospitalier Universitaire Saint PierreMasimo Corporation; Centre Hospitalier Universitaire BrugmannCompletedOut-Of-Hospital Cardiac Arrest | Oxygen ToxicityBelgium